Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer

Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer

<p>Table S1. Results of genome-wide CRISPR/Cas9 screening of HCC-1428/LTED cells.</p>

保存先:
書誌詳細
第一著者: Nicole A. Traphagen (16677391) (author)
その他の著者: Gary N. Schwartz (16005870) (author), Steven Tau (16677394) (author), Alyssa M. Roberts (16677397) (author), Amanda Jiang (15117790) (author), Sarah R. Hosford (16677400) (author), Jonathan D. Marotti (16005879) (author), Abigail E. Goen (16677403) (author), Bianca A. Romo (16677406) (author), Anneka L. Johnson (16677409) (author), Emily-Claire K. Duffy (16677412) (author), Eugene Demidenko (16005894) (author), Paul Heverly (16677415) (author), Yaron Mosesson (16677418) (author), Shannon M. Soucy (16005888) (author), Fred Kolling (16005891) (author), Todd W. Miller (16005897) (author)
出版事項: 2025
主題:
Cancer
Therapeutic Research and Development
Breast Cancer
Drug Mechanisms
Cellular responses to anticancer drugs
Drug Resistance
Reversal of drug resistance
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料